RESUMEN

CD46 is the main receptor for complement protein C3 and plays an important role in adaptive immune responses. CD46 genetic variants are associated with susceptibility to several infectious and autoimmune diseases. Additionally, CD46 function can be subverted by HIV-1 to evade attack by complement, a strategy shared by viruses of other families. We sought to determine the association between CD46 gene variants and HIV-1 acquired through intravenous drug use (IDU) and sexual routes (n = 823). Study subjects were of European ancestry and were HIV-1 infected (n = 438) or exposed but seronegative (n = 387). Genotyping of the rs2796265 SNP located in the CD46 gene region was done by allele-specific real-time PCR. A meta-analysis merging IDU and sexual cohorts indicates that the minor genotype (CC) was associated with increased resistance to HIV-1 infection OR = 0.2, 95% CI (0.07-0.61), p = 0.004. The HIV-1-protective genotype is correlated with reduced CD46 expression and alterations in the ratio of CD46 mRNA splicing isoforms.

Asunto(s)

Predisposición Genética a la Enfermedad , Variación Genética , Infecciones por VIH/genética , Proteína Cofactora de Membrana/genética , Femenino , Regulación de la Expresión Génica , Frecuencia de los Genes/genética , Seronegatividad para VIH/genética , Humanos , Masculino , Polimorfismo de Nucleótido Simple/genética , Abuso de Sustancias por Vía Intravenosa/genética

RESUMEN

NKG2C is an activating NK cell receptor encoded by a gene having an unexpressed deletion variant. Cytomegalovirus (CMV) infection expands a population of NKG2C+ NK cells with adaptive-like properties. Previous reports found that carriage of the deleted NKG2C- variant was more frequent in people living with HIV (PLWH) than in HIV- controls unexposed to HIV. The frequency of NKG2C+ NK cells positively correlated with HIV viral load (VL) in some studies and negatively correlated with VL in others. Here, we investigated the link between NKG2C genotype and HIV susceptibility and VL set point in PLWH. NKG2C genotyping was performed on 434 PLWH and 157 HIV-exposed seronegative (HESN) subjects. Comparison of the distributions of the three possible NKG2C genotypes in these populations revealed that the frequencies of NKG2C+/+ and NKG2C+/- carriers did not differ significantly between PLWH and HESN subjects, while that of NKG2C-/- carriers was higher in PLWH than in HESN subjects, in which none were found (P = 0.03, χ2 test). We were unable to replicate that carriage of at least 1 NKG2C- allele was more frequent in PLWH. Information on the pretreatment VL set point was available for 160 NKG2C+/+, 83 NKG2C+/-, and 6 NKG2C-/- PLWH. HIV VL set points were similar between NKG2C genotypes. The frequency of NKG2C+ CD3- CD14- CD19- CD56dim NK cells and the mean fluorescence intensity (MFI) of NKG2C expression on NK cells were higher on cells from CMV+ PLWH who carried 2, versus 1, NKG2C+ alleles. We observed no correlations between VL set point and either the frequency or the MFI of NKG2C expression. IMPORTANCE We compared NKG2C allele and genotype distributions in subjects who remained HIV uninfected despite multiple HIV exposures (HESN subjects) with those in the group PLWH. This allowed us to determine whether NKG2C genotype influenced susceptibility to HIV infection. The absence of the NKG2C-/- genotype among HESN subjects but not PLWH suggested that carriage of this genotype was associated with HIV susceptibility. We calculated the VL set point in a subset of 252 NKG2C-genotyped PLWH. We observed no between-group differences in the VL set point in carriers of the three possible NKG2C genotypes. No significant correlations were seen between the frequency or MFI of NKG2C expression on NK cells and VL set point in cytomegalovirus-coinfected PLWH. These findings suggested that adaptive NK cells played no role in establishing the in VL set point, a parameter that is a predictor of the rate of treatment-naive HIV disease progression.

Asunto(s)

Predisposición Genética a la Enfermedad/genética , Infecciones por VIH/genética , Subfamília C de Receptores Similares a Lectina de Células NK/genética , Carga Viral/genética , Alelos , Coinfección/genética , Coinfección/inmunología , Coinfección/virología , Infecciones por Citomegalovirus/genética , Infecciones por Citomegalovirus/inmunología , Infecciones por Citomegalovirus/virología , Femenino , Frecuencia de los Genes , Genotipo , Infecciones por VIH/inmunología , Infecciones por VIH/virología , Seronegatividad para VIH/genética , Seronegatividad para VIH/inmunología , Humanos , Células Asesinas Naturales/metabolismo , Masculino , Subfamília C de Receptores Similares a Lectina de Células NK/metabolismo

RESUMEN

BACKGROUND: 25-hydroxylase (CH25H) is an interferon-stimulated gene (ISG), which catalyzes the synthesis of 25-hydroxycholesterol (25HC). 25HC intervenes in metabolic and infectious processes and controls cholesterol homeostasis and influences viral entry into host cells. We verified whether natural resistance to HIV-1 infection in HIV-1-exposed seronegative (HESN) individuals is at least partially mediated by particularities in sterol biosynthesis. METHODS: Peripheral blood mononuclear cells (PBMCs) and monocyte-derived macrophages (MDMs) isolated from 15 sexually exposed HESN and 15 healthy controls were in vitro HIV-1-infected and analyzed for: percentage of IFNα-producing plasmacytoid dendritic cells (pDCs); cholesterol signaling and inflammatory response RNA expression; resistance to HIV-1 infection. MDMs from five healthy controls were in vitro HIV-1-infected in the absence/presence of exogenously added 25HC. RESULTS: IFNα-producing pDCs were augmented in HESN compared with healthy controls both in unstimulated and in in vitro HIV-1-infected PBMCs (P < 0.001). An increased expression of CH25H and of a number of genes involved in cholesterol metabolism (ABCA1, ABCG1, CYP7B1, LXRα, OSBP, PPARγ, SCARB1) was observed as well; this, was associated with a reduced susceptibility to in-vitro HIV-1-infection of PBMCs and MDMs (P < 0.01). Notably, addition of 25HC to MDMs resulted in increased cholesterol efflux and augmented resistance to in-vitro HIV-1-infection. CONCLUSION: Results herein show that in HESN sterol metabolism might be particularly efficient. This could be related to the activation of the IFNα pathway and results into a reduced susceptibility to in-vitro HIV-1 infection. These results suggest a possible basis for therapeutic interventions to modulate HIV-1 infection.

Asunto(s)

Infecciones por VIH/transmisión , Seronegatividad para VIH/genética , Seronegatividad para VIH/fisiología , MicroARNs/sangre , Esteroles/metabolismo , VIH-1 , Humanos , Hidroxicolesteroles , Inmunidad Innata , Leucocitos Mononucleares , Reacción en Cadena en Tiempo Real de la Polimerasa , Esteroide Hidroxilasas/genética , Esteroide Hidroxilasas/metabolismo , Internalización del Virus/efectos de los fármacos

RESUMEN

BACKGROUND: Genetic involvement of Killer Immunoglobulin-like Receptor (KIR) polymorphisms and Human Immunodeficiency Virus (HIV)-exposed seronegative (HESN) compared to HIV-infected (HIVI) individuals has been reported. However, inconsistency of the outcomes reduces precision of the estimates. A meta-analysis was applied to obtain more precise estimates of association. METHODS: A multi-database literature search yielded thirteen case-control studies. Risks were expressed as odds ratios (ORs) and 95% confidence intervals (CIs) with significance set at a two-tailed P-value of ≤ 0.05. We used two levels of analyses: (1) gene content that included 13 KIR polymorphisms (2DL1-3, 2DL5A, 2DL5B, 2DS1-3, 2DS4F, 2DS4D, 2DS5, 3DL1 and 3DS1); and (2) 3DL1/S1 genotypes. Subgroup analysis was ethnicity-based (Caucasians, Asians and Africans). Outlier treatment was applied to heterogeneous effects which dichotomized the outcomes into pre-outlier (PRO) and post-outlier (PSO). Multiple comparisons were addressed with the Bonferroni correction. RESULTS: We generated 52 and 18 comparisons from gene content and genotype analyses, respectively. Of the 70 comparisons, 13 yielded significant outcomes, two (indicating reduced risk) of which survived the Bonferroni correction (Pc). These protective effects pointed to the Caucasian subgroup in 2DL3 (OR 0.19, 95% CI 0.09, 0.40, Pc < 10-3) and 3DS1S1 (OR 0.37, 95% CI 0.24, 0.56, Pc < 10-3). These two PSO outcomes yielded effects of increased magnitude and precision, as well as raised significance and deemed robust by sensitivity analysis. Of the two, the 2DL3 effect was improved with a test of interaction (Pc interaction < 10-4). CONCLUSION: Multiple meta-analytical treatments presented strong evidence of the protective effect (up to 81%) of the KIR polymorphisms (2DL3 and 3DS1S1) among Caucasians. The Asian and African outcomes were inconclusive due to the low number of studies.

Asunto(s)

Infecciones por VIH/epidemiología , Infecciones por VIH/genética , Seronegatividad para VIH/genética , VIH/inmunología , Polimorfismo Genético , Receptores KIR/genética , Estudios de Casos y Controles , Etnicidad/genética , Genotipo , Humanos , Células Asesinas Naturales/inmunología , Riesgo , Población Blanca/genética

RESUMEN

The human papillomavirus (HPV) is present in a significant fraction of head-and-neck squamous cell cancer (HNSCC). The main goal of this study was to identify distinct co-expression patterns between HPV+ and HPV- HNSCC and to provide insights into potential regulatory mechanisms/effects within the analyzed networks. We selected cases deposited in The Cancer Genome Atlas database comprising data of gene expression, methylation profiles and mutational patterns, in addition to clinical information. The intersection among differentially expressed and differentially methylated genes showed the negative correlations between the levels of methylation and expression, suggesting that these genes have their expression levels regulated by methylation alteration patterns in their promoter. Weighted correlation network analysis was used to identify co-expression modules and a systematic approach was applied to refine them and identify key regulatory elements integrating results from the other omics. Three distinct co-expression modules were associated with HPV status and molecular signatures. Validation using independent studies reporting biological experimental data converged for the most significant genes in all modules. This study provides insights into complex genetic and epigenetic particularities in the development and progression of HNSCC according to HPV status, and contribute to unveiling specific genes/pathways as novel therapeutic targets in HNSCC.

Asunto(s)

Biomarcadores de Tumor/genética , Redes Reguladoras de Genes , Seronegatividad para VIH/genética , Seropositividad para VIH/genética , Neoplasias de Cabeza y Cuello/genética , Carcinoma de Células Escamosas de Cabeza y Cuello/genética , Coinfección/genética , Metilación de ADN , Conjuntos de Datos como Asunto , Perfilación de la Expresión Génica , Regulación Neoplásica de la Expresión Génica , VIH , Neoplasias de Cabeza y Cuello/diagnóstico , Neoplasias de Cabeza y Cuello/virología , Humanos , Infecciones por Papillomavirus/diagnóstico , Infecciones por Papillomavirus/genética , Regiones Promotoras Genéticas , Carcinoma de Células Escamosas de Cabeza y Cuello/diagnóstico , Carcinoma de Células Escamosas de Cabeza y Cuello/virología , Transcriptoma

RESUMEN

OBJECTIVE: MicroRNAs (miRNAs) are small noncoding RNAs involved in the posttranscriptional regulation of gene expression that play important roles in viral infections. Alterations of specific miRNAs are described in HIV infection, suggesting a role for miRNAs in pathogenesis of this disease. We verified whether a particular miRNA signature could be identified in natural resistance to HIV-1. METHODS: Expression level of 84 miRNAs was analyzed by RT-qPCR in plasma and unstimulated peripheral blood mononuclear cell (PBMC) of 30 seronegative individuals repeatedly exposed to HIV-1 (HESN), 30 HIV seropositive subjects (HIV+), and 30 healthy controls (HC). Results were confirmed by individual RT-qPCR in in vitro HIV-1-infected PBMC and in their cell culture medium. Dicer and Drosha expression was analyzed in basal PBMC. RESULTS: Whereas Dicer and Drosha expression was comparable in HESN, HIV+ and HC, several miRNAs were upregulated both in HESN and HIV+ compared with HC. Furthermore, miRNA-29a and miR-223 were upregulated in both unstimulated PBMC and plasma of HESN alone; their expression was reduced upon in vitro HIV-1 infection of HESN PBMC indicating that, upon infection, they are secreted in the extracellular milieu. These results were confirmed by individual qPCR. CONCLUSIONS: Our studies demonstrate that HIV-1 exposure modifies miRNAs expression even in the absence of productive infection. Because those miRNAs that are specifically increased only in HESN have been known to reduce HIV-1 replication, their modulation could represent an important mechanism in resistance to HIV-1 infection.

Asunto(s)

Infecciones por VIH/transmisión , Seronegatividad para VIH/genética , MicroARNs/sangre , ARN Helicasas DEAD-box/genética , VIH-1 , Humanos , Reacción en Cadena en Tiempo Real de la Polimerasa , Ribonucleasa III/genética

RESUMEN

Limited reports are available on association of HLA-B with HIV infection from India, a home to the third largest population of HIV infected people in the world. This emphasizes the need to have more information specifically the genetic constitution of HIV serodiscordant couples (DCs), where one spouse is seropositive (HSP) while the other remains seronegative (HSN) even after repeated exposure. Hence, aim of this study was to document association of HLA-B with HIV infection in DCs living in Mumbai, India. A cohort was designed to enroll DCs attending the ICTC/Shakti Clinic of KEM Hospital, Mumbai. A group of unexposed volunteers were also enrolled as healthy controls (HC). HLA-B alleles were typed using sequence-specific oligonucleotide probes. Allele frequency comparison was done using 2×2 contingency tables. Results were considered significant, when p<0.05 with two-tailed Fisher's exact test. At HLA-B locus, the frequencies of HLA-B*40;-B*35;-B*07;-B*15;-B*51;-B*44;-B*52;-B*37 and -B*57 were found in decreasing order in the population. Frequency of HLA-B*35 allele was significantly higher (HSP vs HSN; p<0.02 and HSP vs HC; p<0.04) in HSP. HLA-B*40 (HSN vs HSP; p<0.01 and HC vs HSP; p<0.01) and HLA-B*18 (HSN vs HSP; p<0.02) were significantly associated with HSN. Both HSN and HC had similar HLA-B*35 and -B*40 allele frequency. HLA-B*57 allele was observed in 15 individuals (3.69%). However, HLA-B*57:01 which is known to be associated with adverse reactions against Abacavir was observed in 7 of them. HLA-B*39 was observed exclusively in HSP. Our observation in DCs confirmed the association of HLA-B*35 with susceptibility while HLA-B*40 (specifically *B40:06), -B*18 with protection. These identified alleles can be used as possible marker associated with HIV transmission. In India, HLA screening is not carried out before initiation of HIV treatment. However, the presence of HLA-B*57:01 in the population emphasizes the importance of such screening to predict/avoid Abacavir hypersensitivity.

Asunto(s)

Infecciones por VIH/inmunología , Seronegatividad para VIH/inmunología , Seropositividad para VIH/inmunología , VIH-1/inmunología , Antígenos HLA-B/inmunología , Alelos , Estudios de Cohortes , Femenino , Frecuencia de los Genes , Infecciones por VIH/genética , Infecciones por VIH/virología , Seronegatividad para VIH/genética , Seropositividad para VIH/genética , Seropositividad para VIH/virología , VIH-1/fisiología , Antígenos HLA-B/genética , Antígeno HLA-B18/genética , Antígeno HLA-B18/inmunología , Antígeno HLA-B35/genética , Antígeno HLA-B35/inmunología , Antígeno HLA-B40/genética , Antígeno HLA-B40/inmunología , Prueba de Histocompatibilidad/métodos , Interacciones Huésped-Patógeno/inmunología , Humanos , India , Masculino , Esposos

RESUMEN

Killer immunoglobulin-like receptors (KIRs) regulate natural killer (NK) cells in a human leukocyte antigen (HLA)-dependent manner. KIR/HLA mismatched hematopoietic stem cell transplants induce alloreactive NK cells, which prevent leukemia relapse. Certain KIR/HLA combinations protect against HIV-1 infection, but the effect of KIR/HLA mismatches between sexual partners has never been investigated. In this study, we analyzed the effect of allogeneic KIR/HLA combinations on HIV-1 transmission in a West African population of HIV-1-discordant and concordant couples. HIV-1-discordant couples were characterized by recipient partners with homozygous KIR2DL2, and by a mismatched recipient partner KIR2DL1/HLA-C2 with index partner HLA-C1/C1 combination expected to allow licensed missing self NK cell killing of index partners' cells. HIV-1-concordant couples on the other hand were characterized by KIR2DL3 homozygous recipient partners with HLA-C1/C2 bearing index partners, resulting in a matched KIR/HLA combination expected to inhibit NK cell killing. In vitro cocultures of healthy donor-derived NK cells and HIV-1 patient-derived CD4(+) T cells confirmed the involvement of these allogeneic KIR/HLA combinations in NK cell-mediated CD4(+) T-cell killing. Our data suggest that KIR/HLA incompatibility between sexual partners confers protection against HIV-1 transmission and that this may be due to alloreactive NK cell killing of the HIV-1-infected partner's cells.

Asunto(s)

Infecciones por VIH/inmunología , Infecciones por VIH/transmisión , VIH-1 , Antígenos HLA/inmunología , Receptores KIR/inmunología , Adulto , África Occidental , Linfocitos T CD4-Positivos/inmunología , Técnicas de Cocultivo , Citotoxicidad Inmunológica , Femenino , Infecciones por VIH/genética , Infecciones por VIH/prevención & control , Seronegatividad para VIH/genética , Seronegatividad para VIH/inmunología , Antígenos HLA/genética , Antígenos HLA-C/genética , Antígenos HLA-C/inmunología , Humanos , Inmunidad Innata , Isoantígenos/genética , Isoantígenos/inmunología , Células Asesinas Naturales/inmunología , Masculino , Persona de Mediana Edad , Receptores KIR/genética , Receptores KIR2DL2/genética , Receptores KIR2DL2/inmunología , Parejas Sexuales

RESUMEN

OBJECTIVE: Large studies describing the profile of high-risk Human papillomavirus (hrHPV) genotypes among women in sub-Saharan Africa are lacking. Here we describe the prevalence and distribution of hrHPV genotypes among HIV-negative women in South Africa, with and without cervical intraepithelial neoplasia (CIN). METHODS: We report data on 8,050 HIV-negative women, aged 17-65 years, recruited into three sequential studies undertaken in Cape Town, South Africa. Women had no history of previous cervical cancer screening. Cervical samples were tested for hrHPV DNA using the Hybrid Capture 2 (HC2) assay and all positive samples were genotyped using a PCR-based assay (Line Blot). Women underwent colposcopy and biopsy/endocervical curettage to determine CIN status. The prevalence and distribution of specific hrHPV genotypes were examined by age and CIN status. RESULTS: Overall, 20.7% (95% CI, 19.9-21.6%) of women were hrHPV-positive by HC2, with women with CIN having the highest rates of positivity. Prevalence decreased with increasing age among women without CIN; but, a bimodal age curve was observed among women with CIN. HPV 16 and 35 were the most common hrHPV genotypes in all age and CIN groups. HPV 45 became more frequent among older women with CIN grade 2 or 3 (CIN2,3). Younger women (17-29 years) had more multiple hrHPV genotypes overall and in each cervical disease group than older women (40-65 years). CONCLUSION: HPV 16, 35, and 45 were the leading contributors to CIN 2,3. The current HPV vaccines could significantly reduce HPV-related cervical disease; however, next generation vaccines that include HPV 35 and 45 would further reduce cervical disease in this population.

Asunto(s)

Seronegatividad para VIH/genética , Papillomaviridae/genética , Displasia del Cuello del Útero/epidemiología , Displasia del Cuello del Útero/virología , Adolescente , Adulto , Distribución por Edad , Anciano , ADN Viral/genética , Femenino , Genotipo , Humanos , Persona de Mediana Edad , Prevalencia , Factores de Riesgo , Sudáfrica/epidemiología , Adulto Joven

RESUMEN

TLR3 recognizes dsRNA and activates antiviral immune responses through the production of inflammatory cytokines and type I IFNs. Genetic association studies have provided evidence concerning the role of a polymorphism in TLR3 (rs3775291, Leu412Phe) in viral infection susceptibility. We genotyped rs3775291 in a population of Spanish HIV-1-exposed seronegative (HESN) individuals who remain HIV seronegative despite repeated exposure through i.v. injection drug use (IDU-HESN individuals) as witnessed by their hepatitis C virus seropositivity. The frequency of individuals carrying at least one 412Phe allele was significantly higher in IDU-HESN individuals compared with that of a matched control sample (odds ratio for a dominant model = 1.87; 95% confidence interval, 1.06-3.34; p = 0.023). To replicate this finding, we analyzed a cohort of Italian, sexually HESN individuals. Similar results were obtained: the frequency of individuals carrying at least one 412Phe allele was significantly higher compared with that of a matched control sample (odds ratio, 1.79; 95% confidence interval, 1.05-3.08; p = 0.029). In vitro infection assays showed that in PBMCs carrying the 412Phe allele, HIV-1(Ba-L) replication was significantly reduced (p = 0.025) compared with that of Leu/Leu homozygous samples and was associated with a higher expression of factors suggestive of a state of immune activation (IL-6, CCL3, CD69). Similarly, stimulation of PBMCs with a TLR3 agonist indicated that the presence of the 412Phe allele results in a significantly increased expression of CD69 and higher production of proinflammatory cytokines including IL-6 and CCL3. The data of this study indicate that a common TLR3 allele confers immunologically mediated protection from HIV-1 and suggest the potential use of TLR3 triggering in HIV-1 immunotherapy.

Asunto(s)

Predisposición Genética a la Enfermedad , Infecciones por VIH/genética , Infecciones por VIH/inmunología , Polimorfismo Genético/inmunología , Receptor Toll-Like 3/genética , Células Cultivadas , Estudios de Cohortes , Variación Genética/inmunología , Infecciones por VIH/prevención & control , Seronegatividad para VIH/genética , Seronegatividad para VIH/inmunología , Humanos , Italia , Leucina/genética , Masculino , Fenilalanina/genética , Estudios Prospectivos , España

RESUMEN

BACKGROUND: Natural killer (NK) cells are members of the innate immune system that play an important role in the defense against viral infection. They are also involved in the regulation of adaptive immune responses through cytokine secretion and the interaction with antigen-presenting cells. However, their role in HIV infection is only partially understood. OBJECTIVE: Here we studied the phenotype and function of NK cells of highly HIV-exposed but seronegative (HESN) uninfected commercial sex workers from Kenya who can be epidemiologically defined as relatively resistant to HIV infection. DESIGN: The purpose of this study was to gain insight into the role of NK cells in mediating resistance to HIV-1. This information can be used to better understand protection from infection which can be used for informing future design of effective prophylactics and therapeutics for HIV. METHODS: Whole blood samples were collected from study participants and isolated NK cells and dendritic cells were used in assays for phenotyping and cell function. RESULTS: Activated NK cells from resistant women killed autologous immature dendritic cells more efficiently and also secreted more interferon (IFN)-γ than those of uninfected, susceptible women. Interestingly, NK cells from HIV-resistant women were significantly more effective in inducing secretion of IL-12 in immature dendritic cells. CONCLUSIONS: These data suggest that an altered NK cell-dendritic cell interaction plays an important role in the protection from infection with HIV-1.

Asunto(s)

Células Dendríticas/inmunología , Seronegatividad para VIH/inmunología , Inmunidad Innata , Células Asesinas Naturales/inmunología , Exposición Profesional , Trabajadores Sexuales , Adulto , Complejo CD3/inmunología , Antígeno CD56/inmunología , Células Cultivadas , Ensayo de Inmunoadsorción Enzimática , Femenino , Anticuerpos Anti-VIH/inmunología , Seronegatividad para VIH/genética , VIH-1/inmunología , Humanos , Inmunidad Innata/inmunología , Inmunofenotipificación , Kenia/epidemiología , Exposición Profesional/estadística & datos numéricos , Trabajadores Sexuales/estadística & datos numéricos

RESUMEN

OBJETIVO: Establecer la frecuencia y la relación del alelo CCR5-Δ32 con la infección y la progresión clínica de pacientes VIH+ y en individuos expuestos seronegativos. MATERIAL Y MÉTODOS: Se analizaron 355 muestras, 62 VIH+, 51 individuos expuestos seronegativos y 242 de la población general. Los VIH+ se subdividieron en: a) progresores normales n= 49; b) progresores lentos n= 10, y c) no progresores n= 3. RESULTADOS: Se identificó el genotipo wt/Δ32 en 17.7 por ciento de los VIH+, 13.7 por ciento de los individuos expuestos seronegativos y 6.2 por ciento en la población general. El genotipo Δ32/Δ32 se encontró en 3.9 por ciento de los individuos expuestos seronegativos. Según la progresión clínica de los VIH+, se identificó el genotipo wt/Δ32 en 10.2 por ciento de los progresores normales, 30 por ciento de los progresores lentos y en 100 por ciento de los no progresores. CONCLUSIÓN: El genotipo wt/Δ32 se observó en todos los no progresores, lo que apoya su papel en esta forma de progresión clínica en este grupo.

---

OBJECTIVE: CCR5-Δ32 allele frequency needs to be identified in HIV+ patients and exposed seronegative individuals in Yucatan, Mexico, to understand this mutation's relationship to infection and disease progression. MATERIAL AND METHODS: A total of 355 samples were analyzed: 62 from HIV+ patients, 51 from exposed seronegative individuals and 242 from general population. Infected patients were subdivided into a) normal progressors n= 49; b) slow progressors n= 10, and c) non-progressors n= 3. RESULTS: Genotype wt/Δ32 was identified in 17.7 percent of HIV+, 13.7 percent of exposed seronegative individuals and 6.2 percent of general population. Genotype Δ32/Δ32 was identified in 3.9 percent of exposed seronegative individuals. In infected patients, wt/Δ32 was identified in 10.2 percent of normal progressors, 30 percent of slow progressors and 100 percent of non-progressors. CONCLUSION: Genotype wt/Δ32 was observed in all non-progressing HIV+ patients, supporting its role in this group's disease development and clinical evolution.

Asunto(s)

Femenino , Humanos , Masculino , Frecuencia de los Genes , Seropositividad para VIH/genética , /genética , Estudios Transversales , Progresión de la Enfermedad , Genotipo , Seronegatividad para VIH/genética , México , Estudios Prospectivos , /inmunología

RESUMEN

A very small proportion of people remain negative for HIV infection after repeated HIV-1 viral exposure, which is called HIV-1 resistance. Understanding the mechanism of HIV-1 resistance is important for the development of HIV-1 vaccines and Acquired Immune Deficiency Syndrome (AIDS) therapies. In this study, we analyzed the gene expression profiles of CD4+ T cells from HIV-1-resistant individuals and HIV-susceptible individuals. One hundred eighty-five discriminative HIV-1 resistance genes were identified using the Minimum Redundancy-Maximum Relevance (mRMR) and Incremental Feature Selection (IFS) methods. The virus protein target enrichment analysis of the 185 HIV-1 resistance genes suggested that the HIV-1 protein nef might play an important role in HIV-1 infection. Moreover, we identified 29 infection information exchanger genes from the 185 HIV-1 resistance genes based on a virus-host interaction network analysis. The infection information exchanger genes are located on the shortest paths between virus-targeted proteins and are important for the coordination of virus infection. These proteins may be useful targets for AIDS prevention or therapy, as intervention in these pathways could disrupt communication with virus-targeted proteins and HIV-1 infection.

Asunto(s)

Biología Computacional/métodos , Perfilación de la Expresión Génica , Seronegatividad para VIH/genética , VIH-1/fisiología , Interacciones Huésped-Patógeno/genética , Susceptibilidad a Enfermedades , Proteínas del Virus de la Inmunodeficiencia Humana/metabolismo , Humanos

RESUMEN

Repeated exposure to human immunodeficiency virus (HIV) is not always associated with infection and a subset of individuals remains persistently as HIV-seronegative despite multiple episodes of HIV exposure. These individuals are called HIV-exposed seronegatives (ESN). Several genetic and immunological factors have been involved in this resistance to HIV acquisition. Genetic factors have been linked to genes encoding chemokine receptors and their natural ligands as well as genes of the major histocompatibility complex. Immunological factors include both innate and adaptive immunity. The study of ESN provides a unique opportunity to unveil the mechanisms of natural protection against viral infection. Their better understanding may lead to novel preventive and immune-therapeutic approaches, including vaccines.

Asunto(s)

Resistencia a la Enfermedad , Infecciones por VIH/inmunología , Seronegatividad para VIH , VIH/inmunología , Inmunidad Adaptativa , Resistencia a la Enfermedad/genética , Resistencia a la Enfermedad/inmunología , Genes MHC Clase I , Seronegatividad para VIH/genética , Seronegatividad para VIH/inmunología , Humanos

RESUMEN

Not all individuals exposed to HIV become infected. Understanding why these HIV-exposed seronegative individuals remain uninfected will help inform the development of preventative measures against HIV infection. Interferon regulatory factor-1 (IRF1) plays a critical role both in host antiviral immunity and in HIV-1 replication. This study examined IRF1 expression regulation in the ex vivo peripheral blood mononuclear cells of HIV-exposed seronegative commercial sex workers who can be epidemiologically defined as relatively resistant to HIV infection (HIV-R), versus HIV-uninfected, susceptible controls (HIV-S). Whereas HIV-susceptible individuals demonstrated a biphasic, prolonged increase in IRF1 expression after interferon-γ stimulation, HIV-R individuals demonstrated a robust, but transient response. We also found that the IRF1 promoter in HIV-R was primed by increased basal histone deacetylase-2 binding, independently of transcription regulators, STAT1 and nuclear factor-κB/p65, implicating an epigenetic silencing mechanism. Interestingly, the transitory IRF1 response in HIV-R was sufficient in comparable regulation of interleukin-12 and interleukin-4 expression compared with the HIV-susceptible controls. This is the first study characterizing IRF1 responsiveness in individuals who demonstrate altered susceptibility to HIV infection. These data suggest that transitory IRF1 responsiveness in HIV-R may be one of the key contributors to the altered susceptibility to HIV infection during the early stages of primary HIV infection.

Asunto(s)

Susceptibilidad a Enfermedades , Epigénesis Genética , Infecciones por VIH/genética , Seronegatividad para VIH/genética , Factor 1 Regulador del Interferón/genética , Acetilación/efectos de los fármacos , Estudios de Casos y Controles , Regulación hacia Abajo/efectos de los fármacos , Epigénesis Genética/efectos de los fármacos , Silenciador del Gen/efectos de los fármacos , Sitios Genéticos , Infecciones por VIH/inmunología , Histona Desacetilasa 2/metabolismo , Histonas/metabolismo , Humanos , Factor 1 Regulador del Interferón/metabolismo , Interferón gamma/farmacología , Cinética , FN-kappa B/metabolismo , Regiones Promotoras Genéticas/genética , Unión Proteica/efectos de los fármacos , ARN Mensajero/genética , ARN Mensajero/metabolismo , Factor de Transcripción STAT1/metabolismo , Factor de Transcripción ReIA/metabolismo

RESUMEN

OBJECTIVE: CCR5-Δ32 allele frequency needs to be identified in HIV+ patients and exposed seronegative individuals in Yucatan, Mexico, to understand this mutation's relationship to infection and disease progression. MATERIAL AND METHODS: A total of 355 samples were analyzed: 62 from HIV+ patients, 51 from exposed seronegative individuals and 242 from general population. Infected patients were subdivided into a) normal progressors n= 49; b) slow progressors n= 10, and c) non-progressors n= 3. RESULTS: Genotype wt/Δ32 was identified in 17.7% of HIV+, 13.7% of exposed seronegative individuals and 6.2% of general population. Genotype Δ32/Δ32 was identified in 3.9% of exposed seronegative individuals. In infected patients, wt/Δ32 was identified in 10.2% of normal progressors, 30% of slow progressors and 100% of non-progressors. CONCLUSION: Genotype wt/Δ32 was observed in all non-progressing HIV+ patients, supporting its role in this group's disease development and clinical evolution.

Asunto(s)

Frecuencia de los Genes , Seropositividad para VIH/genética , Receptores CCR5/genética , Estudios Transversales , Progresión de la Enfermedad , Femenino , Genotipo , Seronegatividad para VIH/genética , Humanos , Masculino , México , Estudios Prospectivos , Receptores CCR5/inmunología

RESUMEN

PURPOSE: Radiosensitivity in relation to the human immunodeficiency virus (HIV) status is important in South Africa as the prevalence of HIV infections is high. In this study the in vitro chromosomal radiosensitivity of HIV positive individuals was investigated and compared with that of HIV negative individuals. MATERIALS AND METHODS: Blood samples from 59 HIV positive and 39 HIV negative individuals were exposed in vitro to doses of 6MV X-rays ranging from 1-4 Gy. Chromosomal radiosensitivity was assessed with the micronucleus assay. Micronuclei are a measure of chromosomal damage and were quantified in at least 500 binucleated lymphoblasts (BN) per sample. Un-irradiated control samples from each donor were also analysed. RESULTS: In 47% of HIV positive individuals difficulties with cell stimulation by adding phytohaemagglutinin (PHA) to blood cultures were noticed which resulted in insufficient yield of BN for microscopic analysis. Micronuclei frequencies were consistently higher in irradiated lymphocytes obtained from HIV positive individuals compared to that observed in cells from HIV negative donors. Data for both groups were fitted to the linear-quadratic equation Y = alphaD + betaD(2) where Y is the number of micronuclei in 500 binucleated cells and D is the dose in Gy. The fitted parameters for respectively HIV positive and HIV negative lymphocytes are alpha = 80.17 Gy(-1), beta = 14 Gy(-2) and alpha = 54.5 Gy(-1), beta = 16.2 Gy(-2). The confidence ellipses of these parameters are separated indicating that the increase in radiosensitivity is statistically significant. CONCLUSION: T-lymphocytes of HIV infected individuals were considerably more sensitive to X-rays compared to that of HIV negative donors. This may have implications for normal tissue tolerance during radiotherapy as well as for the radiological health of radiation workers.

Asunto(s)

Cromosomas Humanos/genética , Cromosomas Humanos/efectos de la radiación , Seropositividad para VIH/genética , Seropositividad para VIH/patología , Tolerancia a Radiación/efectos de la radiación , Rayos X/efectos adversos , Adulto , Estudios de Casos y Controles , Relación Dosis-Respuesta en la Radiación , Femenino , Citometría de Flujo , Seronegatividad para VIH/genética , Seronegatividad para VIH/efectos de la radiación , Seropositividad para VIH/sangre , Humanos , Linfocitos/citología , Linfocitos/efectos de la radiación , Masculino , Micronúcleos con Defecto Cromosómico/efectos de la radiación , Pruebas de Micronúcleos , Persona de Mediana Edad , Sudáfrica , Adulto Joven

RESUMEN

The CCR5Delta32 mutation does not account for HIV-1 resistance in the majority of persons who are repeatedly exposed to HIV-1 by high-risk activities but remain seronegative and uninfected. Therefore, we investigated the impact of CCR5 59029 A/G and CCL3L1 copy number polymorphism on HIV-1 disease susceptibility and progression among HIV-1-infected and HIV-1-exposed seronegative North Indians. HIV-1-seropositive (HSP, n = 196) patients, stratified on the basis of disease severity (Stages I, II, and III) and HIV-1-exposed seronegative (HES, n = 47) individuals were genotyped for CCR5-59029 A/G polymorphism by PCR-RFLP and CCL3L1 copy number by the real-time TaqMan PCR method. A group of ethnically matched HIV-1-seronegative (HSN, n = 315) healthy volunteers were also genotyped as controls. Statistical analysis was done by SPSS software. The CCR5-59029 AG genotype was significantly higher in the HES compared with the HSP group (57.44% vs. 37.24%, p = 0.014). The CCL3L1 mean copy number of HES was higher compared with the HSP groups (3.148 +/- 0.291 vs. 2.795 +/- 0.122, p = 0.212), but was not significant when compared with independent samples t test. Possession of CCL3L1 copies < or = 2 or >2 was not associated with enhanced or reduced risk of HIV-1 acquisition. Gene-gene interaction studies showed enrichment of the CCR5-59029AG*CCL3L1>2 genotype in the HES group when compared with the HSP group (31.91% vs. 15.81%, p = 0.021, OR = 0.401, CI = 0.194-0.826). The increased frequency of the CCR5-59029AG*CCL3L1>2 genotype among HES individuals led us to conclude that the CCR5-59029 AG genotype and CCL3L1 gene dose appeared to have synergistic or interactive effects and are expected to be involved in the host innate resistance to HIV-1 infection.

Asunto(s)

Quimiocinas CC/genética , Variaciones en el Número de Copia de ADN , Seronegatividad para VIH , Seropositividad para VIH , Receptores CCR5/genética , Adulto , Quimiocinas CC/metabolismo , Progresión de la Enfermedad , Susceptibilidad a Enfermedades , Femenino , Genotipo , Infecciones por VIH/genética , Infecciones por VIH/fisiopatología , Infecciones por VIH/transmisión , Infecciones por VIH/virología , Seronegatividad para VIH/genética , Seronegatividad para VIH/inmunología , Seropositividad para VIH/genética , Seropositividad para VIH/inmunología , Seropositividad para VIH/transmisión , Seropositividad para VIH/virología , VIH-1 , Humanos , India/epidemiología , Masculino , Receptores CCR5/metabolismo , Conducta Sexual

Asunto(s)

Seronegatividad para VIH/inmunología , Susceptibilidad a Enfermedades , Anticuerpos Anti-VIH/biosíntesis , Seronegatividad para VIH/genética , Humanos , Inmunidad Celular , Inmunidad Innata , Terminología como Asunto

RESUMEN

The present study investigated the prevalence of mutations in the -550 (H/L) and -221 (X/Y) mannose-binding lectin (MBL) gene promoter regions and their impact on infection by human immunodeficiency virus 1 (HIV-1) in a population of 128 HIV-1 seropositive and 97 seronegative patients. The allele identification was performed through the sequence-specific primer polymerase chain reaction method, using primer sequences specific to each polymorphism. The evolution of the infection was evaluated through CD4+ T-lymphocyte counts and plasma viral load. The allele and haplotype frequencies among HIV-1-infected patients and seronegative healthy control patients did not show significant differences. CD4+ T-lymphocyte counts showed lower levels among seropositive patients carrying haplotypes LY, LX and HX, as compared to those carrying the HY haplotype. Mean plasma viral load was higher among seropositive patients with haplotypes LY, LX and HX than among those carrying the HY haplotype. When promoter and exon 1 mutations were matched, it was possible to identify a significantly higher viral load among HIV-1 infected individuals carrying haplotypes correlated to low serum levels of MBL. The current study shows that haplotypes related to medium and low MBL serum levels might directly influence the evolution of viral progression in patients. Therefore, it is suggested that the identification of haplotypes within the promoter region of the MBL gene among HIV-1 infected persons should be further evaluated as a prognostic tool for AIDS progression.

Asunto(s)

Infecciones por VIH/genética , VIH-1/genética , Lectina de Unión a Manosa/genética , Polimorfismo Genético/genética , Recuento de Linfocito CD4 , Estudios de Casos y Controles , Progresión de la Enfermedad , Marcadores Genéticos/genética , Predisposición Genética a la Enfermedad/genética , Infecciones por VIH/virología , Seronegatividad para VIH/genética , Haplotipos/genética , Humanos , Mutación , Reacción en Cadena de la Polimerasa , Regiones Promotoras Genéticas/genética , Carga Viral